Fig. 6. The performance of plasma NfL concentration cutoffs to identify neurodegenerative disorders in >65 and <65 years.
The performance of plasma neurofilament light (NfL) concentration cutoffs to identify neurodegenerative disorders in >65 (A) and <65 (B). The KCL and Lund cohorts are combined for this analysis. AD Alzheimer’s disease, ALS amyotrophic lateral sclerosis, CBS corticobasal syndrome, DLB dementia with Lewy bodies, DS Down syndrome, DSAD Down syndrome Alzheimer’s disease, EOAD early-onset Alzheimer’s disease, FTD frontotemporal dementia. MCI mild cognitive impairment, MSA multiple system atrophy, PD Parkinson’s disease, PDD Parkinson’s disease dementia, PSP progressive supranuclear palsy, SCD subjective cognitive decline, VaD vascular dementia.